Immunogen reported $296.8M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Amgen AMGN:US $ 24380M 5281M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Astellas Pharma 4503:JP Y 876454M 7739M
AstraZeneca AZN:LN 26.69B 583M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Cerulean Pharma CERU:US $ 48.24M 34.18M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Emergent Biosolutions EBS:US $ 1111.5M 50.6M
Exelixis EXEL:US $ 1662.03M 68.78M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Immunogen IMGN:US $ 296.8M 22.41M
Intrexon XON:US $ 153.09M 3.59M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Macrogenics MGNX:US $ 334.7M 32.3M
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Novartis NVS:US $ 26253M 2445M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Seattle Genetics SGEN:US $ 3114.61M 16.1M